Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14687444 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)
Condition: Osteoarthritis
Interventions: Drug: MK0663, etoricoxib / Duration of Treatment: 6 Weeks;   Drug: Comparator: diclofenac sodium / Duration of Treatment: 6 Weeks

Indicates status has not been verified in more than two years